Artikel von Marvin Herzberger

Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.

Latest from Marvin Herzberger

ENI

Eni: In Transition between Traditional Oil Business and Targeted Energy Transition

Eni is consistently advancing its transformation from a traditional oil company to an integrated energy...

Power Shift in Seoul: SK Hynix Overtakes Samsung in Market Capitalization as the Most Valuable Company in the South Korean Market!

SK Hynix has surpassed Samsung in market capitalization and leads the South Korean stock market. ...

Fervo Energy

Fervo Energy Integrates AI in Geothermal Energy and Accelerates Growth as an Infrastructure Provider

Cooperation with Nvidia and PNNL aims to leverage AI for the optimization of geothermal plants. The...

SpaceX: How Starlink V3 and Starship Successes Elevate the Company to a New Level - Arete Sees 124% Price Potential

SpaceX (SPCX) launched on June 12th under the ticker SPCX with a historic valuation of around 1.78 trillion...

Nexans: A new Trend Boost Could Bring the Cable Specialist Back Into Focus!

Nexans is a French specialist in cable systems. I could already address the stock multiple times, especially...

Infineon Technologies: DAX Stock with 121% Price Increase Since the Beginning of the Year - What’s Behind it?

Semiconductor company leads the index after significant price increase Forecast raised due to strong...

Delta Electronics: Thai Heavyweight Benefits from Significant Capital Rotation in Asian Emerging Markets!

Reallocation of $4.2 billion from Indonesia strengthens Thailand's stock market through international...

Immix Biopharma

Immix Biopharma: Convincing CAR-T Study Data and $2 Billion Revenue Potential Bring Focus to Stock

The Business Model and Breakthrough in Cell Therapy Immix Biopharma (IMMX) is a clinical biopharmaceutical...

Straumann: High Willingness to Pay for a Radiant Smile Enables Upward Revision of Profitability Forecast!

Straumann (i.) is a specialist in solutions within the field of aesthetic dentistry. The company has...

D-Wave Quantum: Industry-first Gate Model Quantum Simulator and Commercial Scaling!

Launch of the industry's first gate model simulator for error-aware programming of quantum applications....

FPS: Since the IPO in February, the stock price has risen by 137% - Data centers prove to be the growth engine!

Stock price has climbed from $27 since the IPO in February 2026 to over $64 High demand for power...

Nano Nuclear Energy: With Strategic Acquisitions and AI Excitement Towards a Vertically Integrated Nuclear Future - Experts See 87% Price Potential

The renaissance of nuclear energy in global financial markets is in full swing. While traditional large...

Parsons Corp.: Margin Icreases, Insider Buying and a High Order Backlog Could Reveal Hidden Potential!

The Parsons Corp. (PSN) (i.) has caught my attention. At the end of April, mixed results for the first...

Uber: Acceleration of the Transition to an Autonomous Platform through new Partnerships!

Uber accelerates the transition to an autonomous platform through new partnerships in Europe. The...

Amkor Technology: Strategic Realignment through US Manufacturing and Partnership with TSMC

Expansion of US production capacities through close partnership with TSMC to strengthen local supply...

Camp4 Therapeutics

Camp4 Therapeutics: JPMorgan Upgrade and Progress on CMP-002 Highlight RNA Pioneer

The Business Model of Targeted Gene Upregulation Camp4 Therapeutics (CAMP) is a biopharmaceutical...

Redcare Pharmacy: For me, the Raised Forecast was a buy Trigger!

Redcare Pharmacy (i.) has evolved from a pure online pill distributor into a comprehensive European healthcare...

Robinhood Restructures: Job Cuts and Focus on Efficiency

The workforce reduction of 10% will result in restructuring costs of approximately $28 million in...

Mobileye: Will the Transformation from Supplier to Independent Robotaxi Operator Succeed?

Mobileye plans to launch a vertically integrated robotaxi service in the USA by 2027, starting with...

Rezolve AI: AI Disruption in E-Commerce Meets $300 Million Share Buyback

The weakness of software stocks has also affected Rezolve AI (i.). Since February, the stock has merely...